UBC breakthrough opens door to $100 ultrasound machine

UBC breakthrough opens door to $100 ultrasound machine

  • September 12, 2018
Table of Contents

UBC breakthrough opens door to $100 ultrasound machine

Engineers at the University of British Columbia have developed a new ultrasound transducer, or probe, that could dramatically lower the cost of ultrasound scanners to as little as $100. Their patent-pending innovation—no bigger than a Band-Aid—is portable, wearable and can be powered by a smartphone. Conventional ultrasound scanners use piezoelectric crystals to create images of the inside of the body and send them to a computer to create sonograms.

Researchers replaced the piezoelectric crystals with tiny vibrating drums made of polymer resin, called polyCMUTs (polymer capacitive micro-machined ultrasound transducers), which are cheaper to manufacture. Sonograms produced by the UBC device were as sharp as or even more detailed than traditional sonograms produced by piezoelectric transducers, said co-author Edmond Cretu, professor of electrical and computer engineering. Co-author Robert Rohling, also a professor of electrical and computer engineering, said the next step in the research is to develop a wide range of prototypes and eventually test their device in clinical applications.

Source: ubc.ca

Share :
comments powered by Disqus

Related Posts

‘Ground-breaking’ diabetes insulin drug trialled in Cardiff

‘Ground-breaking’ diabetes insulin drug trialled in Cardiff

A ‘ground-breaking’ drug that helps people with diabetes re-grow insulin-making cells has been developed. About 19,000 people live with Type 1 of the condition in Wales and 90% have less than 5% of these cells left. This means they have to inject insulin

Read More
AI System Approved For Diabetic Retinopathy Diagnosis

AI System Approved For Diabetic Retinopathy Diagnosis

A system designed by a University of Iowa ophthalmologist that uses artificial intelligence (AI) to detect diabetic retinopathy without a person interpreting the results earned Food and Drug Administration (FDA) authorization in April, following a clinical trial in primary care offices. Results of that study were published Aug. 28 online in Nature Digital Medicine, offering the first look at data that led to FDA clearance for IDx-DR, the first medical device that uses AI for the autonomous detection of diabetic retinopathy. The clinical trial, which also was the first study to prospectively assess the safety of an autonomous AI system in patient care, compared the performance of IDx-DR to the gold standard diagnostic for diabetic retinopathy, which is the leading cause of vision loss in adults and one of the most severe complications for the 30.3 million Americans living with diabetes.

Read More